• Center on Health Equity and Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Podcast: This Week in Managed Care—Heart Disease Treatment and Other Health News

Podcast

Every week, The American Journal of Managed Care® recaps the top managed care news of the week, and you can now listen to it on our podcast, Managed Care Cast.

Every week, The American Journal of Managed Care® recaps the top managed care news of the week.

This week, the top managed care news included research that shows stents may offer no more value than drugs for some heart patients; a ban on flavored tobacco products gains momentum; a survey finds most American families struggle with social factors that impact health.

iTunes

TuneIn

Stitcher

Spotify

Listen above or through one of these podcast services:

In Stable Heart Disease, Study Finds Stents Might Be No Better Than Drugs

American Heart Association Scientific Sessions 2019

What We're Reading: Vaping Ban Bill; Anal Cancer Rates; Medical Bill Protections

Social Factors of Health Impacting Majority of US Families, Survey Says

Patients Need More Education Regarding the Purpose of Precision Medicine Trials

One Size Does Not Always Fit All in Value Assessment

Value Assessment and Heterogeneity: Another Side to the Story

The American Journal of Managed Care—November 2019

Read more about the stories in this podcast:

Related Videos
Patrick Vermersch, MD, PhD
Video 1 - "Diagnosing and Understanding the Pathogenesis of Bronchiectasis"
Video 4 - "Challenges in Autoantibody Screening for Type 1 Diabetes"
Jeff Stark, MD, vice president, head of medical immunology, UCB
Video 7 - "Prior Authorization and Access to Targeted Treatment for Ph+ ALL Patients"
Video 7 - "Prior Authorization and Access to Targeted Treatment for Ph+ ALL Patients"
Video 6 - "Community Partnership: Increasing Public Awareness of CVD"
Video 6 - "Community Partnership: Increasing Public Awareness of CVD"
Screenshot of Raajit Rampal, MD, PhD
Related Content
© 2024 MJH Life Sciences
AJMC®
All rights reserved.